— Know what they know.
Not Investment Advice

MNKD NASDAQ

MannKind Corporation
1W: +2.8% 1M: +20.8% 3M: -40.2% YTD: -40.9% 1Y: -24.1% 3Y: -24.6% 5Y: -23.2%
$3.38
+0.07 (+2.11%)
 
Weekly Expected Move ±14.2%
$2 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 61 · $1.0B mcap · 304M float · 2.26% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
49.6 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 4.2%
Cost Advantage
54
Intangibles
44
Switching Cost
69
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MNKD shows a Weak competitive edge (49.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 4.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$7
Low
$9
Avg Target
$10
High
Based on 3 analysts since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 3Sell: 7Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$8.20
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-07 Mizuho Securities Anthony Petrone $8 $7 -1 +96.6% $3.56
2026-05-07 Wells Fargo Initiated $10 +180.9% $3.56
2026-05-07 H.C. Wainwright $11 $10 -1 +180.9% $3.56
2026-04-13 Mizuho Securities Initiated $8 +210.7% $2.58
2026-04-08 Truist Financial $9 $6 -3 +129.9% $2.61
2025-11-24 Truist Financial Initiated $9 +78.9% $5.03
2025-09-02 H.C. Wainwright $9 $11 +2 +91.6% $5.74
2025-08-26 RBC Capital Douglas Miehm Initiated $8 +100.0% $4.00
2025-08-25 H.C. Wainwright Initiated $9 +130.8% $3.90
2024-08-28 Oppenheimer Steven Lichtman Initiated $12 +123.0% $5.38
2023-10-10 Wedbush Andreas Argyrides Initiated $10 +136.4% $4.23

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
4
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MNKD receives an overall rating of C+. Strongest factors: DCF (4/5), ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-06 C C+
2026-05-04 C+ C
2026-03-19 C C+
2026-03-18 C+ C
2026-03-16 C C+
2026-03-13 C+ C
2026-03-09 C C+
2026-02-26 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

20 Grade D
Profitability
20
Balance Sheet
35
Earnings Quality
57
Growth
49
Value
23
Momentum
48
Safety
0
Cash Flow
26
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MNKD scores highest in Earnings Quality (57/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.42
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
0.79
Possible Manipulator
Ohlson O-Score
-4.58
Bankruptcy prob: 1.0%
Low Risk
Credit Rating
CCC
Score: 17.2/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -0.79x
Accruals: -7.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MNKD scores -4.42, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MNKD scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MNKD's score of 0.79 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MNKD's implied 1.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MNKD receives an estimated rating of CCC (score: 17.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-43.57x
PEG
0.25x
P/S
2.89x
P/B
-17.60x
P/FCF
59.38x
P/OCF
40.10x
EV/EBITDA
37.10x
EV/Revenue
2.93x
EV/EBIT
92.11x
EV/FCF
83.13x
Earnings Yield
-3.17%
FCF Yield
1.68%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MNKD currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.837
NI / EBT
×
Interest Burden
-2.489
EBT / EBIT
×
EBIT Margin
0.032
EBIT / Rev
×
Asset Turnover
0.608
Rev / Assets
×
Equity Multiplier
-9.135
Assets / Equity
=
ROE
36.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MNKD's ROE of 36.8% is driven by Asset Turnover (0.608), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.38
Median 1Y
$2.94
5th Pctile
$0.96
95th Pctile
$9.02
Ann. Volatility
66.5%
Analyst Target
$8.20
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael E. Castagna
Chief Executive Officer
$789,436 $7,689,480 $9,300,485
Dominic Marasco President,
Endocrine Business Unit
$447,596 $6,269,015 $6,980,472
David B. Thomson
EVP, General Counsel and Secretary
$520,748 $2,133,480 $3,155,248
Stuart A. Tross
EVP, Human Resources
$438,709 $2,133,480 $2,945,695
Christopher B. Prentiss
Chief Financial Officer
$470,085 $2,133,480 $2,886,799

CEO Pay Ratio

38:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,300,485
Avg Employee Cost (SGA/emp): $243,471
Employees: 592

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
592
+45.5% YoY
Revenue / Employee
$589,470
Rev: $348,966,000
Profit / Employee
$9,904
NI: $5,863,000
SGA / Employee
$243,471
Avg labor cost proxy
R&D / Employee
$112,074
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 46.4% 42.7% 41.5% 48.2% 44.9% 50.0% 38.0% 31.0% 20.6% 13.6% 4.8% -3.4% -4.7% -8.7% -17.0% -18.5% -20.2% -18.0% -9.0% 36.8% 36.84%
ROA -85.1% -78.4% -37.7% -43.7% -40.7% -45.4% -28.4% -23.1% -15.4% -10.2% -3.1% 2.2% 3.0% 5.6% 6.3% 6.9% 7.5% 6.7% 1.0% -4.0% -4.03%
ROIC 31.4% 29.8% 29.9% 39.5% 46.0% 47.9% 38.1% 29.0% 15.8% 7.1% -2.6% -9.6% -14.6% -17.3% -28.7% -31.0% -26.8% -30.3% 64.2% 4.2% 4.22%
ROCE -2.1% -1.8% -23.6% -28.9% -24.3% -27.1% -27.5% -20.3% -9.8% -2.7% 4.0% 10.7% 12.6% 16.4% 22.0% 23.3% 22.0% 20.0% 6.2% 1.8% 1.85%
Gross Margin 57.4% 55.5% 8.6% 8.3% 31.6% 46.8% 55.3% 60.1% 70.7% 72.2% 69.1% 71.9% 71.8% 74.3% 74.5% 77.6% 73.1% 75.4% 78.5% 75.8% 75.78%
Operating Margin -44.1% -29.7% -1.9% -1.8% -1.1% -29.3% -35.5% -14.8% 3.5% 9.9% 13.4% 25.2% 22.9% 18.2% 34.5% 28.5% 6.9% 22.9% -6.9% -3.3% -3.31%
Net Margin -1.5% -19.9% -2.2% -2.2% -1.5% -44.0% -49.8% -24.1% -10.8% 3.4% 2.4% 16.0% -2.8% 16.5% 9.7% 16.8% 0.9% 9.7% -14.2% -18.4% -18.43%
EBITDA Margin -1.3% -2.1% -1.8% -1.7% -90.9% -23.9% -29.7% -7.8% 11.5% 16.3% 16.9% 33.0% 18.3% 34.0% 24.2% 34.3% 12.7% 21.8% -2.2% 3.8% 3.77%
FCF Margin -72.4% -73.6% -97.0% -1.2% -1.4% -1.3% -88.5% -56.2% -36.2% -17.9% -4.2% 1.4% 7.3% 10.8% 11.5% 7.3% 9.5% 13.8% 3.9% 3.5% 3.53%
OCF Margin -63.6% -60.4% -81.8% -96.0% -1.2% -1.2% -80.9% -47.7% -16.9% 5.7% 17.1% 17.6% 16.5% 15.5% 14.9% 9.9% 11.4% 15.5% 5.2% 5.2% 5.22%
ROA 3Y Avg snapshot only 2.14%
ROIC Economic snapshot only 2.55%
Cash ROA snapshot only 2.38%
Cash ROIC snapshot only 7.50%
CROIC snapshot only 5.07%
NOPAT Margin snapshot only 2.93%
Pretax Margin snapshot only -7.92%
R&D / Revenue snapshot only 20.11%
SGA / Revenue snapshot only 48.01%
SBC / Revenue snapshot only 4.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -15.78 -13.71 -13.56 -9.86 -11.04 -8.22 -15.88 -15.20 -22.79 -35.47 -98.75 173.33 121.43 83.03 67.74 53.60 35.52 57.25 303.77 -31.58 -43.570
P/S Ratio 18.23 13.36 14.54 13.24 14.73 10.51 13.91 8.43 6.84 6.29 5.93 6.55 5.74 6.70 6.55 5.42 3.86 5.33 5.10 2.09 2.894
P/B Ratio -7.53 -6.03 -5.24 -4.43 -4.62 -3.83 -5.54 -4.32 -4.32 -4.43 -4.79 -5.98 -5.79 -7.27 -23.71 -20.48 -14.78 -21.23 -34.91 -14.80 -17.602
P/FCF -25.20 -18.15 -14.99 -11.20 -10.81 -8.15 -15.72 -15.01 -18.89 -35.10 -141.24 474.07 78.16 62.02 56.94 73.99 40.47 38.71 131.59 59.38 59.385
P/OCF 110.54 34.58 37.11 34.87 43.10 43.96 54.84 33.72 34.36 98.39 40.10 40.101
EV/EBITDA -20.83 -19.02 -20.08 -13.79 -17.65 -13.24 -27.02 -30.83 -74.22 26115.22 56.08 31.73 26.32 25.71 22.17 17.73 12.84 20.84 40.06 37.10 37.101
EV/Revenue 18.99 14.05 15.67 14.46 16.03 11.63 15.09 9.34 7.58 6.95 5.81 6.45 5.65 6.62 6.02 4.92 3.37 4.86 5.97 2.93 2.931
EV/EBIT -19.68 -17.75 -18.37 -12.85 -15.85 -12.00 -24.04 -25.89 -53.65 -198.19 78.22 36.65 30.07 29.04 25.10 20.18 14.82 24.41 53.81 92.11 92.107
EV/FCF -26.25 -19.10 -16.16 -12.23 -11.76 -9.01 -17.06 -16.64 -20.94 -38.81 -138.55 466.83 76.92 61.24 52.39 67.13 35.27 35.25 153.90 83.13 83.133
Earnings Yield -6.3% -7.3% -7.4% -10.1% -9.1% -12.2% -6.3% -6.6% -4.4% -2.8% -1.0% 0.6% 0.8% 1.2% 1.5% 1.9% 2.8% 1.7% 0.3% -3.2% -3.17%
FCF Yield -4.0% -5.5% -6.7% -8.9% -9.3% -12.3% -6.4% -6.7% -5.3% -2.8% -0.7% 0.2% 1.3% 1.6% 1.8% 1.4% 2.5% 2.6% 0.8% 1.7% 1.68%
PEG Ratio snapshot only 0.246
EV/OCF snapshot only 56.137
EV/Gross Profit snapshot only 3.858
Acquirers Multiple snapshot only 78.885
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.08 1.08 4.54 4.54 4.54 4.54 3.49 3.49 3.49 3.49 3.59 3.59 3.59 3.59 3.28 3.28 3.28 3.28 1.70 1.70 1.705
Quick Ratio 1.01 1.01 4.39 4.39 4.39 4.39 3.17 3.17 3.17 3.17 3.31 3.31 3.31 3.31 2.94 2.94 2.94 2.94 1.50 1.50 1.498
Debt/Equity -0.68 -0.68 -1.38 -1.38 -1.38 -1.38 -1.15 -1.15 -1.15 -1.15 -1.11 -1.11 -1.11 -1.11 -0.61 -0.61 -0.61 -0.61 -9.28 -9.28 -9.278
Net Debt/Equity
Debt/Assets 1.14 1.14 0.90 0.90 0.90 0.90 0.98 0.98 0.98 0.98 0.57 0.57 0.57 0.57 0.12 0.12 0.12 0.12 0.60 0.60 0.598
Debt/EBITDA -1.82 -2.05 -4.91 -3.94 -4.86 -4.32 -5.18 -7.41 -17.86 6136.13 13.22 5.97 5.12 3.96 0.62 0.58 0.60 0.65 9.10 16.61 16.611
Net Debt/EBITDA -0.83 -0.94 -1.45 -1.16 -1.43 -1.27 -2.11 -3.02 -7.28 2501.11 -1.09 -0.49 -0.42 -0.33 -1.93 -1.81 -1.89 -2.05 5.81 10.60 10.599
Interest Coverage -4.99 -4.34 -3.88 -5.17 -3.14 -3.13 -2.53 -1.86 -0.89 -0.25 0.59 1.35 1.42 1.70 1.80 1.84 2.10 1.97 1.04 0.29 0.294
Equity Multiplier -0.60 -0.60 -1.53 -1.53 -1.53 -1.53 -1.18 -1.18 -1.18 -1.18 -1.93 -1.93 -1.93 -1.93 -5.00 -5.00 -5.00 -5.00 -15.53 -15.53 -15.526
Cash Ratio snapshot only 1.002
Debt Service Coverage snapshot only 0.729
Cash to Debt snapshot only 0.362
FCF to Debt snapshot only 0.027
Defensive Interval snapshot only 293.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.74 0.80 0.35 0.33 0.31 0.35 0.32 0.42 0.51 0.57 0.52 0.58 0.64 0.69 0.66 0.68 0.69 0.72 0.59 0.61 0.608
Inventory Turnover 6.35 7.39 6.41 6.97 7.46 8.71 3.98 4.34 4.43 4.21 2.50 2.59 2.83 2.98 2.71 2.68 2.68 2.76 2.61 2.74 2.745
Receivables Turnover 19.28 21.05 16.85 15.63 14.65 17.02 9.26 11.92 14.68 16.39 12.55 14.17 15.67 16.86 21.38 22.29 22.60 23.50 13.91 14.38 14.382
Payables Turnover 5.59 6.50 6.20 6.74 7.22 8.42 6.39 6.96 7.11 6.76 6.08 6.32 6.91 7.28 9.36 9.23 9.25 9.52 10.41 10.96 10.961
DSO 19 17 22 23 25 21 39 31 25 22 29 26 23 22 17 16 16 16 26 25 25.4 days
DIO 57 49 57 52 49 42 92 84 82 87 146 141 129 122 134 136 136 132 140 133 133.0 days
DPO 65 56 59 54 51 43 57 52 51 54 60 58 53 50 39 40 39 38 35 33 33.3 days
Cash Conversion Cycle 11 11 20 22 23 20 74 62 56 55 115 109 99 94 113 113 113 109 131 125 125.1 days
Fixed Asset Turnover snapshot only 4.377
Operating Cycle snapshot only 158.4 days
Cash Velocity snapshot only 2.106
Capital Intensity snapshot only 2.196
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 20.3% 29.8% 15.8% 5.5% -11.9% -6.3% 32.2% 83.4% 1.4% 1.3% 99.4% 74.9% 57.1% 51.3% 43.5% 32.5% 21.5% 17.4% 22.2% 21.2% 21.23%
Net Income -94.8% -75.8% -41.4% -54.5% -1.6% -23.0% -8.0% 24.3% 45.8% 67.9% 86.3% 1.1% 1.2% 1.7% 3.3% 2.5% 1.8% 35.5% -78.7% -1.8% -1.79%
EPS -67.1% -61.6% -32.1% -51.3% 0.1% -18.6% -3.0% 27.7% 48.2% 69.0% 88.9% 1.1% 1.2% 1.7% 3.6% 2.6% 1.4% 23.8% -80.3% -1.8% -1.83%
FCF 26.6% -76.7% -1.2% -1.3% -65.8% -64.2% -20.6% 12.9% 36.0% 67.8% 90.5% 1.0% 1.3% 1.9% 4.9% 6.0% 57.9% 49.7% -58.8% -41.7% -41.70%
EBITDA -1.4% -84.4% -31.8% -66.8% 12.3% -11.3% 5.4% 47.0% 72.9% 1.0% 1.4% 2.2% 4.3% 1462.6% 2.8% 80.9% 48.4% 6.3% -32.9% -65.5% -65.50%
Op. Income -40.3% -31.8% 1.9% -32.1% -46.5% -60.9% -36.3% 21.3% 63.1% 84.1% 1.1% 1.6% 2.7% 5.5% 7.4% 1.5% 44.4% 35.1% -46.7% -82.9% -82.85%
OCF Growth snapshot only -36.01%
Asset Growth snapshot only 1.01%
Debt Growth snapshot only 8.93%
Shares Change snapshot only -3.94%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 74.9% 70.7% 39.4% 18.7% 7.4% 6.5% 16.5% 27.6% 36.7% 41.2% 45.1% 50.2% 49.4% 48.6% 55.8% 62.0% 66.3% 60.3% 51.8% 41.1% 41.11%
Revenue 5Y -12.9% -15.5% -17.0% -18.3% 31.2% 53.4% 60.1% 62.6% 60.9% 48.2% 39.9% 36.2% 33.5% 35.3% 36.9% 37.3% 38.0% 39.9% 40.3% 40.31%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 70.5% 11.9% -11.7% -13.4% 6.4% 27.3% 42.1% 45.8% 49.8% 56.5% 57.3% 59.1% 78.7% 1.0% 1.2% 1.2% 84.7% 61.0% 60.98%
Gross Profit 5Y -9.5% -22.0% -26.8% -31.3% 79.2% 51.7% 43.1% 39.7% 42.9% 47.4% 47.1% 44.6% 45.8% 45.8% 45.78%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 8.7% 8.7% 43.9% 43.9% 43.9% 43.9% 46.6% 46.6% 46.6% 46.6% 63.6% 63.6% 63.6% 63.6% 7.0% 7.0% 7.0% 7.0% 39.0% 39.0% 38.95%
Assets 5Y -3.0% -3.0% 24.6% 24.6% 24.6% 24.6% 28.4% 28.4% 28.4% 28.4% 34.6% 34.6% 34.6% 34.6% 33.3% 33.3% 33.3% 33.3% 48.8% 48.8% 48.80%
Equity 3Y
Book Value 3Y
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.93 0.24 0.36 0.48 0.55 0.85 0.94 0.87 0.77 0.79 0.80 0.76 0.72 0.72 0.79 0.84 0.86 0.89 0.92 0.96 0.963
Earnings Stability 0.10 0.29 0.25 0.27 0.34 0.16 0.13 0.15 0.19 0.12 0.20 0.20 0.27 0.23 0.41 0.46 0.60 0.59 0.64 0.49 0.494
Margin Stability 0.00 0.18 0.67 0.75 0.72 0.04 0.00 0.00 0.00 0.10 0.67 0.77 0.73 0.72 0.77 0.74 0.70 0.71 0.79 0.85 0.847
Rev. Growth Consistency 1.00 0.50 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.83 0.50 0.99 0.91 0.97 0.90 0.82 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.20 0.200
Earnings Smoothness 0.00 0.05 0.70 0.00
ROE Trend
Gross Margin Trend 0.07 0.00 -0.10 -0.17 -0.26 -0.28 -0.13 -0.00 0.13 0.21 0.23 0.26 0.26 0.24 0.18 0.14 0.10 0.06 0.06 0.03 0.032
FCF Margin Trend 0.08 0.02 0.00 -0.18 -0.41 -0.65 -0.15 0.30 0.68 0.83 0.89 0.89 0.94 0.84 0.58 0.35 0.24 0.17 0.00 -0.01 -0.008
Sustainable Growth Rate
Internal Growth Rate 2.3% 3.1% 5.9% 6.8% 7.4% 8.2% 7.2% 1.0%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.55 0.62 0.76 0.72 0.89 0.93 0.92 0.86 0.56 -0.32 -2.86 4.67 3.48 1.93 1.54 0.98 1.05 1.67 3.09 -0.79 -0.788
FCF/OCF 1.14 1.22 1.19 1.23 1.15 1.08 1.09 1.18 2.14 -3.15 -0.24 0.08 0.45 0.70 0.77 0.74 0.83 0.89 0.75 0.68 0.675
FCF/Net Income snapshot only -0.532
OCF/EBITDA snapshot only 0.661
CapEx/Revenue 8.7% 13.2% 15.2% 22.2% 17.8% 10.1% 7.6% 8.4% 19.3% 23.6% 21.3% 16.3% 9.1% 4.7% 3.4% 2.6% 1.9% 1.7% 1.3% 1.7% 1.70%
CapEx/Depreciation snapshot only 0.359
Accruals Ratio -0.38 -0.30 -0.09 -0.12 -0.05 -0.03 -0.02 -0.03 -0.07 -0.13 -0.12 -0.08 -0.08 -0.05 -0.03 0.00 -0.00 -0.04 -0.02 -0.07 -0.072
Sloan Accruals snapshot only -0.140
Cash Flow Adequacy snapshot only 3.079
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 7.0% 5.5% 5.0% 4.6% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.0% -1.0% -0.2% -0.1% -0.0% -2.6% -1.4% -1.9% -2.1% -0.6% -0.5% -0.4% -0.2% 0.0% -0.0% -0.1% 0.0% -0.1% -0.4% -1.0% -1.00%
Total Shareholder Return -1.0% -1.0% -0.2% -0.1% -0.0% -2.6% -1.4% -1.9% -2.1% -0.6% -0.5% -0.4% -0.2% 0.0% -0.0% -0.1% 0.0% -0.1% -0.4% -1.0% -1.00%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.15 0.82 0.85 0.86 0.90 0.91 0.91 0.95 4.17 0.84 0.837
Interest Burden (EBT/EBIT) 1.20 1.23 1.26 1.19 1.32 1.32 1.40 1.54 2.12 5.05 -0.70 0.26 0.30 0.41 0.45 0.46 0.52 0.49 0.04 -2.49 -2.489
EBIT Margin -0.97 -0.79 -0.85 -1.13 -1.01 -0.97 -0.63 -0.36 -0.14 -0.04 0.07 0.18 0.19 0.23 0.24 0.24 0.23 0.20 0.11 0.03 0.032
Asset Turnover 0.74 0.80 0.35 0.33 0.31 0.35 0.32 0.42 0.51 0.57 0.52 0.58 0.64 0.69 0.66 0.68 0.69 0.72 0.59 0.61 0.608
Equity Multiplier -0.55 -0.55 -1.10 -1.10 -1.10 -1.10 -1.34 -1.34 -1.34 -1.34 -1.55 -1.55 -1.55 -1.55 -2.67 -2.67 -2.67 -2.67 -9.13 -9.13 -9.135
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.35 $-0.32 $-0.32 $-0.37 $-0.35 $-0.38 $-0.33 $-0.27 $-0.18 $-0.12 $-0.04 $0.03 $0.04 $0.08 $0.09 $0.09 $0.11 $0.09 $0.02 $-0.08 $-0.08
Book Value/Share $-0.72 $-0.72 $-0.83 $-0.83 $-0.83 $-0.81 $-0.95 $-0.95 $-0.94 $-0.93 $-0.76 $-0.76 $-0.90 $-0.86 $-0.27 $-0.25 $-0.25 $-0.25 $-0.16 $-0.17 $-0.19
Tangible Book/Share $-0.72 $-0.72 $-0.83 $-0.83 $-0.83 $-0.81 $-0.96 $-0.96 $-0.96 $-0.95 $-0.77 $-0.77 $-0.91 $-0.88 $-0.30 $-0.27 $-0.28 $-0.28 $-0.39 $-0.40 $-0.40
Revenue/Share $0.30 $0.33 $0.30 $0.28 $0.26 $0.29 $0.38 $0.49 $0.60 $0.66 $0.61 $0.69 $0.91 $0.94 $0.98 $0.93 $0.97 $1.01 $1.11 $1.17 $1.17
FCF/Share $-0.22 $-0.24 $-0.29 $-0.33 $-0.35 $-0.38 $-0.34 $-0.27 $-0.22 $-0.12 $-0.03 $0.01 $0.07 $0.10 $0.11 $0.07 $0.09 $0.14 $0.04 $0.04 $0.04
OCF/Share $-0.19 $-0.20 $-0.25 $-0.27 $-0.31 $-0.35 $-0.31 $-0.23 $-0.10 $0.04 $0.11 $0.12 $0.15 $0.15 $0.15 $0.09 $0.11 $0.16 $0.06 $0.06 $0.06
Cash/Share $0.27 $0.27 $0.81 $0.81 $0.80 $0.79 $0.65 $0.65 $0.64 $0.64 $0.91 $0.91 $1.08 $1.04 $0.68 $0.61 $0.63 $0.63 $0.55 $0.56 $0.43
EBITDA/Share $-0.27 $-0.24 $-0.23 $-0.29 $-0.23 $-0.26 $-0.21 $-0.15 $-0.06 $0.00 $0.06 $0.14 $0.20 $0.24 $0.27 $0.26 $0.25 $0.23 $0.17 $0.09 $0.09
Debt/Share $0.50 $0.49 $1.15 $1.15 $1.14 $1.12 $1.09 $1.09 $1.09 $1.07 $0.84 $0.84 $1.00 $0.96 $0.16 $0.15 $0.15 $0.15 $1.51 $1.54 $1.54
Net Debt/Share $0.23 $0.23 $0.34 $0.34 $0.34 $0.33 $0.45 $0.45 $0.44 $0.44 $-0.07 $-0.07 $-0.08 $-0.08 $-0.51 $-0.47 $-0.48 $-0.48 $0.96 $0.98 $0.98
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.425
Altman Z-Prime snapshot only -11.116
Piotroski F-Score 4 4 4 4 4 4 3 4 4 5 7 8 8 8 7 6 6 6 5 4 4
Beneish M-Score -3.99 -3.58 3.43 2.91 0.42 0.28 -1.36 -1.14 -1.57 -1.93 -2.82 -2.65 -2.64 -2.63 -2.12 -2.00 -2.09 -2.23 0.70 0.79 0.794
Ohlson O-Score snapshot only -4.583
Net-Net WC snapshot only $-1.79
EVA snapshot only $-14513130.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only CCC
Credit Score 18.99 19.25 20.00 20.00 20.00 20.00 20.00 20.00 20.00 18.55 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 19.57 17.20 17.200
Credit Grade snapshot only 17
Credit Trend snapshot only -2.800
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 6
Sector Credit Rank snapshot only 6

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms